SEC Form 4 · accession 0001127602-18-009566
BIOCRYST PHARMACEUTICALS INC · BCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alane P Barnes
Officer — VP, General Counsel & Corp Sec
Period of report
Feb 28, 2018
Accepted (ET)
Mar 2, 2018 · 2:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882796
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 28, 2018 | M | 6,709 | $3.26 | A | 85,768 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Emp. Stock Option (Right to Buy) | $3.26 | Feb 28, 2018 | M | 6,709 | D | Mar 14, 2009 | Mar 14, 2018 | Common Stock | 6,709 | 0 | D |